Adam Cohen, MD
Inova Health Care Services · Inova Schar Cancer Institute · University of Pennsylvania
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Adam Cohen, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 08:18 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT07831369 · VISTA: Valproic Acid, Irinotecan, and Simvastatin for Recurrent GliomaInova Health Care Services · recruiting · Glioblastoma, Astrocytoma, IDH-Mutant, Grade 4 · principal investigator
- N/ANCT05519774 · Assessment of Cancer Related Brain Fog Using the Test of Strategic LearningInova Health Care Services · completed · Brain Fog · principal investigator
- Ph2NCT04965688 · Biology Guided Therapy for Breast Cancer for ER PositiveInova Health Care Services · terminated · Breast Cancer, Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer · principal investigator
- Ph2NCT04680468 · Study of Belantamab Mafodotin as Pre- and Post-autologous Stem Cell Transplant and Maintenance for Multiple MyelomaUniversity of Pennsylvania · active not recruiting · Myeloma · principal investigator
- Ph1NCT02546167 · CART-BCMA Cells for Multiple MyelomaUniversity of Pennsylvania · completed · Multiple Myeloma · principal investigator
- Ph1NCT01789242 · A Safety Study of Carfilzomib in Patients With Previously-Treated Systemic Light Chain AmyloidosisCriterium, Inc. · completed · Amyloidosis, Systemic Light Chain Amyloidosis · principal investigator
- Ph1/Ph2NCT01580969 · Repeat Radiation, Minocycline and Bevacizumab in Patients With Recurrent GliomaUniversity of Utah · completed · Recurrent Glioma · principal investigator
- Ph1NCT01007695 · Molecular Signature of Valproic Acid in Breast Cancer With Functional Imaging Assessment - a PilotUniversity of Utah · terminated · Cancer · study chair
- Ph1NCT00836225 · Safety, Tolerability and Activity Study of Multiple Doses of ISIS-SGLT2Rx in Healthy VolunteersIonis Pharmaceuticals, Inc. · completed · Type 2 Diabetes Mellitus · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 08:18 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in glioblastoma.